* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
2042EPHA3C0035412Rhabdomyosarcoma0.00300763924902685BEFREE;LHGDN
2042EPHA3C0024121Lung Neoplasms0.00273291246481375LHGDN
2042EPHA3C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma0.00273291246481375LHGDN
2042EPHA3C0030297Pancreatic Neoplasm0.002407028523288GAD
2042EPHA3C0006142Malignant neoplasm of breast0.0010989071368524BEFREE
2042EPHA3C0678222Breast Carcinoma0.0010989071368524BEFREE
2042EPHA3C2239176Liver carcinoma0.0010989071368524BEFREE
2042EPHA3C0007134Renal Cell Carcinoma0.0008241803526393BEFREE
2042EPHA3C0025202melanoma0.0008241803526393BEFREE
2042EPHA3C0027819Neuroblastoma0.0008241803526393BEFREE
2042EPHA3C0596263Carcinogenesis0.0008241803526393BEFREE
2042EPHA3C0700095Central neuroblastoma0.0008241803526393BEFREE
2042EPHA3C0751951Central Core Myopathy (disorder)0.0008241803526393BEFREE
2042EPHA3C0001418Adenocarcinoma0.0005494535684262BEFREE
2042EPHA3C0002736Amyotrophic Lateral Sclerosis0.0005494535684262BEFREE
2042EPHA3C0017636Glioblastoma0.0005494535684262BEFREE
2042EPHA3C0017638Glioma0.0005494535684262BEFREE
2042EPHA3C0024591Malignant hyperpyrexia due to anesthesia0.0005494535684262BEFREE
2042EPHA3C0027627Neoplasm Metastasis0.0005494535684262BEFREE
2042EPHA3C0029925Ovarian Carcinoma0.0005494535684262BEFREE
2042EPHA3C0242379Malignant neoplasm of lung0.0005494535684262BEFREE
2042EPHA3C0280100solid tumor0.0005494535684262BEFREE
2042EPHA3C0376358Malignant neoplasm of prostate0.0005494535684262BEFREE
2042EPHA3C0600139Prostate carcinoma0.0005494535684262BEFREE
2042EPHA3C0684249Carcinoma of lung0.0005494535684262BEFREE
2042EPHA3C1140680Malignant neoplasm of ovary0.0005494535684262BEFREE
2042EPHA3C1306460Primary malignant neoplasm of lung0.0005494535684262BEFREE
2042EPHA3C1332347Atypical Ductal Breast Hyperplasia0.0005494535684262BEFREE
2042EPHA3C1704380Distal Renal Tubular Acidosis0.0005494535684262BEFREE
2042EPHA3C0002726Amyloidosis0.0002747267842131BEFREE
2042EPHA3C0003873Rheumatoid Arthritis0.0002747267842131BEFREE
2042EPHA3C0004775Bartter Disease0.0002747267842131BEFREE
2042EPHA3C0004936Mental disorders0.0002747267842131BEFREE
2042EPHA3C0007102Malignant tumor of colon0.0002747267842131BEFREE
2042EPHA3C0008497Choriocarcinoma0.0002747267842131BEFREE
2042EPHA3C0009402Colorectal Carcinoma0.0002747267842131BEFREE
2042EPHA3C0010674Cystic Fibrosis0.0002747267842131BEFREE
2042EPHA3C0011226Hepatitis D Infection0.0002747267842131BEFREE
2042EPHA3C0014544Epilepsy0.0002747267842131BEFREE
2042EPHA3C0017921Glycogen storage disease type II0.0002747267842131BEFREE
2042EPHA3C0018801Heart failure0.0002747267842131BEFREE
2042EPHA3C0018802Congestive heart failure0.0002747267842131BEFREE
2042EPHA3C0019163Hepatitis B0.0002747267842131BEFREE
2042EPHA3C0019196Hepatitis C0.0002747267842131BEFREE
2042EPHA3C0019348Herpes Simplex Infections0.0002747267842131BEFREE
2042EPHA3C0019829Hodgkin Disease0.0002747267842131BEFREE
2042EPHA3C0020538Hypertensive disease0.0002747267842131BEFREE
2042EPHA3C0020550Hyperthyroidism0.0002747267842131BEFREE
2042EPHA3C0022595Keratosis Follicularis0.0002747267842131BEFREE
2042EPHA3C0023448Lymphoid leukemia0.0002747267842131BEFREE
2042EPHA3C0023470Myeloid Leukemia0.0002747267842131BEFREE
2042EPHA3C0023903Liver neoplasms0.0002747267842131BEFREE
2042EPHA3C0024623Malignant neoplasm of stomach0.0002747267842131BEFREE
2042EPHA3C0025149Medulloblastoma0.0002747267842131BEFREE
2042EPHA3C0027873Neuromyelitis Optica0.0002747267842131BEFREE
2042EPHA3C0032002Pituitary Diseases0.0002747267842131BEFREE
2042EPHA3C0079772T-Cell Lymphoma0.0002747267842131BEFREE
2042EPHA3C0085110Severe Combined Immunodeficiency0.0002747267842131BEFREE
2042EPHA3C0085281Addictive Behavior0.0002747267842131BEFREE
2042EPHA3C0085292Stiff-Person Syndrome0.0002747267842131BEFREE
2042EPHA3C0162283Nephrogenic Diabetes Insipidus0.0002747267842131BEFREE
2042EPHA3C0221055Paramyotonia Congenita (disorder)0.0002747267842131BEFREE
2042EPHA3C0234166Hyperexplexia0.0002747267842131BEFREE
2042EPHA3C0238286Mucolipidosis Type IV0.0002747267842131BEFREE
2042EPHA3C0275524Coinfection0.0002747267842131BEFREE
2042EPHA3C0279626Squamous cell carcinoma of esophagus0.0002747267842131BEFREE
2042EPHA3C0280141Acute Undifferentiated Leukemia0.0002747267842131BEFREE
2042EPHA3C0342751Generalized glycogen storage disease of infants0.0002747267842131BEFREE
2042EPHA3C0345904Malignant neoplasm of liver0.0002747267842131BEFREE
2042EPHA3C0375023Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site0.0002747267842131BEFREE
2042EPHA3C0376544Hematopoietic Neoplasms0.0002747267842131BEFREE
2042EPHA3C0410538Pseudoachondroplasia0.0002747267842131BEFREE
2042EPHA3C0424295Hyperactive behavior0.0002747267842131BEFREE
2042EPHA3C0553580Ewings sarcoma0.0002747267842131BEFREE
2042EPHA3C0677776Hereditary Breast and Ovarian Cancer Syndrome0.0002747267842131BEFREE
2042EPHA3C0699790Colon Carcinoma0.0002747267842131BEFREE
2042EPHA3C0699791Stomach Carcinoma0.0002747267842131BEFREE
2042EPHA3C0751214Hyperalgesia, Thermal0.0002747267842131BEFREE
2042EPHA3C1142166Brugada Syndrome (disorder)0.0002747267842131BEFREE
2042EPHA3C1168401Squamous cell carcinoma of the head and neck0.0002747267842131BEFREE
2042EPHA3C1266099Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation0.0002747267842131BEFREE
2042EPHA3C1275126TNF receptor-associated periodic fever syndrome (TRAPS)0.0002747267842131BEFREE
2042EPHA3C1378511Undifferentiated leukemia0.0002747267842131BEFREE
2042EPHA3C1458155Mammary Neoplasms0.0002747267842131BEFREE
2042EPHA3C1519670Tumor Angiogenesis0.0002747267842131BEFREE
2042EPHA3C1527249Colorectal Cancer0.0002747267842131BEFREE
2042EPHA3C1621958Glioblastoma Multiforme0.0002747267842131BEFREE
2042EPHA3C1832918Brody myopathy0.0002747267842131BEFREE
2042EPHA3C1833429D-2-hydroxyglutaric aciduria0.0002747267842131BEFREE
2042EPHA3C1857451Acth-Independent Macronodular Adrenal Hyperplasia0.0002747267842131BEFREE
2042EPHA3C1857800CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 20.0002747267842131BEFREE
2042EPHA3C1862941Amyotrophic Lateral Sclerosis, Sporadic0.0002747267842131BEFREE
2042EPHA3C2678485LONG QT SYNDROME 9 (disorder)0.0002747267842131BEFREE
2042EPHA3C2746066Combined D-2- and L-2-hydroxyglutaric aciduria0.0002747267842131BEFREE
2042EPHA3C3714580Hypokalemic periodic paralysis type 10.0002747267842131BEFREE
2042EPHA3C3887505DYSFUNCTION - SKIN DISORDERS0.0002747267842131BEFREE